Drug Type miRNA |
Synonyms BND 6482, BND6482 |
Target |
Action inhibitors |
Mechanism miR-21 inhibitors(microRNA 21 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United States | 01 Nov 2024 | |
Lung Cancer | Preclinical | United States | 01 Nov 2024 |